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The present study, in which 66 cases of oral squamous
cell carcinoma were reviewed retrospectively, is the largest
series to have been investigated so far. It appears that in
these cases of squamous cell carcinoma, HPV-associated
oral infection occurs only rarely in the black population of
the western Northern Transvaal.
The authors wish to thank Mrs H. van der Wait for secretarial
services and Or A. Gunders for help in preparing the manuscript.
The study was supported by grants from thePoliomyelitis
Research Foundation, Sandringham, and the Medical Research
Council of South Africa.
REFERENCES
1. Chang F. Role of papillomaviruses. J Clin Pathol 1990; 43: 269-276.
2. Woodworth CD, Bowden PE, Doniger J, et aJ. Characterization of normal human
exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18
DNA. Cancer Res 1988; 48: 4620·4628.
3. Woodworth CD, Doniger J, Di Poalo JA. Immortalization of human foreskin
keratinocytes by various human papillomavirus DNAs corresponds to their
association with cervical carcinoma. J Viral 1989; 63: 159-164.
4. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer
(Mini-review). Virology 1991; 184: 9-13.
5. Scully C, Cox MF, Prime SS, Maitland NJ. Papillomaviruses: the current status in
relation to oral disease. Oral Med 1988; 65: 526-532.
6. Chang F, Syrjanen S, Kellokoski J, Syrjanen K. Human papillomavirus (HPV) infections
and their associations with oral disease. J Oral Pathol Med 1991; 20: 305-317.
7. Shroyer KR, Greer RO. Detection of human papillomavirus DNA by in situ
hybridisation and polymerase chain reaction in premalignant and malignant oral
lesions. Oral Surg Oral Med Oral Patho/1991; 71: 708-713.
8. Zeus MS, Miller CS, White OK. In situ hybridization analysis of human
papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol 1991;
71: 714-720.
9. Young SK, Min KW. In situ DNA hybridization analysis of oral papillomas,
leuko"plakias, and carcinomas for human papillomavirus. Oral Surg Oral Med Oral
Pa/hol 1991; 71: 726-729.
10. Tsuchiya H, Tomita Y, Shirasawa H, Tanzawa H, Sato K, Simizu 8. Detection of
human papillomavirus in head and neck tumors with DNA hybridisation and
immunohistochemical analysis. Oral Surg Oral Med Oral Pathol 1991; 71: 708-713.
11. Chang KW} Chang CS, Lai KS, Chou MJ, Choo KB. High prevalence of human
papillomavirus infection and possible association with betel quid chewing and
smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989; 28: 57-61.
12. Johnson NW. Oro-facial neoplasms: Global epidemiology, risk factors' and
recommendations for research. Report of the Commission on Oral Health, Research
and Epidemiology of the Federation Dentaire International, London, 1990.
13. Fleming 0, Shear M, Altini M. Intraoral squamous cell carcinomas in South Africa. J
Dent Assoc South Atr 1982; 37: 541-544.
14. Pringle JH, Primrose L, Kind CN, Talbot IC, Lauder L In situ hybridization
demonstration of poly-adenylated RNA sequences in formalin-fixed paraffin sections
using a biotinylated oligonucleotide poly mprobe. J PathoJ 1989; 158: 279-286.
15. Wynder EL, Muskinski MH, Spirak JC. Tobacco and alcohol consumption in relation
to the development of multiple primary cancers. Cancer 1977; 40: 1872-1878.
16. Pindborg JJ. Epidemiology of oral cancer and precancer. In: Pindborg JJ, eel. Oral
Cancer and Precancer. Bristol: John Wright & Sons Ltd, 1980: 126-128.
17. Syrjanen KJ. Human papillomavirus (HPV) infections of the female genital tract and
their associations with intra-epithelial neoplasia and squamous cell carcinoma.
Pa/hol Annu 1986; 21: 53-87.
18. Howell RE, Gallant L. Human papillomavirus type 16 in an oral squamous carcinoma
and its metastasis. OraJ Surg Oral Med Oral Patho/1992; 74: 620-626.
19. Chang F, Syrjanen S, Nuutinen J, Karja J, Syrjanen K. Detection of human
papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization
and polymerase chain reaction. Arch DermatoJ Res 1990; 282: 493-497.
20. Higgs TW, Moore NJ, Badawi DY, Taub FE. Type-specific human papillomavirus
detection in formalin-fixed, paraffin-embedded tissue sections using nonradioactive
deoxyribonucleic acid probes. Lab lnvest 1990; 63: 557-567.
, 21. Watts SL, Brewer EE, Fry TL. Human papiJIomavirus DNA types in squamous cell
carcinomas of the head and neck_ Oral Surg Oral Med Oral Pathol 1991; 71: 701-707.
Accepted 9 Nov 1993.
Assessment of quality of
life by clinicians -
experience of a practical
method in lung cancer
patients
Raymond Abratt, Gary Viljoen
Objective. To evaluate a practical method (brief scale) of
assessing the quality of life in patients with lung cancer.
Design. To compare the scores obtained by means of
the brief scale with those obtained on formal tests.. The
brief scale consists of an Outlook score (measuring
psychological status) and a Support score (measu.';ing
psychosocial support). The formal tests were the f10spital
Anxiety and Depression Scale (HADS) for psychological
status, and the Rotterdam Symptom Checklist (RSCL) and
Spitzer QL-Index for quality-of-Iife assessment.
Setting. Lung cancer follow-up clinic, Groote Schuur
Hospital.
Participants. A total of 40 patients selected by random
sample.
Main outcome measures. The correlation between the
brief scale and standard formal tests.
Results. The HADS indicated that psychological
morbidity was present in 30% of patients. Both the RSCL
and the Spitzer QL-Index indicated a significantly poor
quality of life in 25% of patients. The Outlook score
correlated with both psychological status and quality of
life. The Support score correlated with psychological
status but not with the assessment of quality of life. It did,
however, correlate with the independent evaluation of
social support in the Spitzer QL-Index.
Conclusions. The brief scale is a cost-effective and
useful tool for quality of life assessment in the clinical
management of patients with lung and other cancers.
S Atr Med J 1995; 85: 896-898.
The practice of medicine is concerned not only with
prolongation of the survival of patients, but also with their
quality of life. However, although SUbjective assessment of
the factors affecting quality of life may form part of the
clinician's management of a patient with lung cancer, it may
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vary from one clinician to another and may not be as
comprehensive as it should be. In recent years, increasing
attention has therefore been given to a more scientific
assessment of quality of life which includes emotional,
social and spiritual aspects of the patient's well-being.'
Numerous instruments to assess quality of life have been
introduced over the past decade, and these are still being
developed in the light of experience.
The methodology of these tests has been developed by
social scientists without the significant involvement of
clinicians! Patients are usually asked to complete
questionnaires that are then evaluated by psychologists.
This technique has been useful in determining the
prevalence of psychological morbidity such as depression or
anxiety, and to compare the effects on the quality of life of
two different forms of treatment. However, such a procedure
is of limited value to the practising clinician and is not cost-
effective.
Patients and methods
The quality of life of patients depends on many different
factors, including biological, psychological and social
factors.' The measurement of biological factors such as
symptoms and signs, general well-being, e.g. performance3
(Table I), and specific organ function, e.g. dyspnoea score:
are already part of routine clinical practice. In order to
include and document psychological and social factors, we
needed an objective assessment tool which could be scored
easily and which would also be meaningful to others. It
could also serve as a focus for further understanding and as
a screening device for psychosocial morbidity. It was also
important that it be brief enough for clinicians to memorise
and use routinely.
Table I. World Health Organisation' Performance status score
(abbreviated)
Able to carry out normal activity without restriction 0
Symptomatic but fully ambulatory 1
Capable of self-care and up and about more than 50%
of waking hours 2
Confined to bed or chair more than 50% of waking hours 3
Confined to bed or chair 4
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Table 11. The Outlook and Support scores
Brief quality-oHife scale
Outlook (Assess the patient's general mood and outlook since
the last visit)
1a. Have you felt down or depressed (most of the time?/only
sometimes?/never?)
1b. Have you felt anxious or afraid (most of the time?/only
sometimes?/never?)
2. Are you able to cope and make plans for the future? (If not,
determine whether this is because of practi.cal or emotional
reasons.)
Further exploratory questions in the event of anxious or
depressed feelings:
• What do you do when you feel like this? Does it help?
• Do you feel you need help in dealing with these feelings?
Score Calm and positive outlook (1)
Somewhat anxious and/or depressed outlook (2a/2d)
Distinctly anxious and/or depressed outlook (3a/3d)
Support (Assess the patient's quality of emotional and physical
support from others since the last visit)
1. If you feel sad or afraid, or need help, whom do you turn to
for support?
2. Are they able to help you (emotionally - physically?)
Further exploratory questions:
• Have you found it difficult to discuss your illness with those
close to you?
• Have you felt lonely and isolated?
Score Good social/emotional support (coping well) (1)
Moderate social/emotional support (coping) (2)
Poor social/emotional support (not coping) (3)
Patients
Forty patients attending the lung cancer follow-up clinic
were entered into this study on a random basis between
February and July 1993. Their ages ranged from 40 to 80
years with a mean age of 60 years. Thirty-two were men
(80%) and 8 women (20%). Stage of disease and details of
histology are given in Table Ill, and are representative of the
population as a whole. Eighteen (45%) were initially treated
with radiation, 8 (20%) with surgery and 6 (15%) with
chemotherapy, while 8 (20%) were given only symptomatic
treatment.
Table Ill. Patient stage and hjstological findings
Patients attending the clinic routinely undergo evaluation of
physical well-being, which includes level of pain,
performance status and dyspnoea score. Quality-of-Iife




We therefore chose the Spitzer QL-Index as a basis for
our test. The Spitzer QL-Index was developed in 1981 and
is regarded as the most widely used quality-of-Iife scale.'
It consists of five questions, the first three of which assess
physicaVbiological factors by focusing on, firstly, the
patient's activity, secondly the ability to care for one's self
and thirdly, the feeling of well-being. Question four
addresses the level of social support and question five
psychological well-being, both of which are frequently
overlooked in routine clinical assessment, and which
therefore formed the basis of the brief assessment scale
which was developed (Table 11). This assessment tool was
introduced to all professional staff and incorporated into
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Patients in this study also underwent independent
evaluation by a psychologist using the Hospital Anxiety and
Depression Scale (HADS)6 to assess psychological status,
the Rotterdam Symptom Check Ust (RSCL)' and the Spitzer
QL-indexs for quality-of-life assessments. In addition to
psychological assessment, patients and participating
doctors were interviewed to ascertain their reaction to the
introduction of this form of quality-of-life assessment.
Results
The HADS showed that psychological morbidity was present
in 30% of all patients: anxiety in 17,5% and depression in
22,5%. Both the RSCL and the Spitzer QL-Index revealed
significantly poor quality of life in 25% of patients.
The correlations between the different psychological tests
are shown in Table IV. The Outlook score correlated with the
psychological status as measured by the HADS, and the
quality of life as measured by the RSCL and the Spitzer
QL-Index. The Support score correlated with psychological
status, but not with quality of life. However, both the Outlook
and Support scores correlated significantly with
corresponding questions in the Spitzer QL-Index (correlation
= 0,55 and 0,53 for Outlook and Support respectively) which
suggests that the Support question measures the social
support factor as accurately as the full scale.
Table IV. Correlation of the tests
RSCL Spitzer Outlook Support
HADS 0,86' 0,50' 0,61' 0,43'




Patients interviewed responded positively to the
introduction of quality-of-Iife assessment, some
experiencing marked relief at being 'able to discuss issues
which didn't seem part of the clinic before', or 'able to talk
about things that are really worrying'.
The response from doctors was rather more ambivalent,
and included: 'It has improved my communication with
patients'; 'It's good that those patients who have problems
now talk about them'; 'What does one do once one has
asked the questions - one feels that the patients want
something afterwards'; 'It's a stiff and formal way of doing
something I've been doing all along'.
Conclusion
A brief assessment scale, based on the Spitzer QL-Index,
was designed and introduced at the lung cancer clinic at
Groote Schuur Hospital. It was designed to include
assessment of psychological and social factors, which are
unfortunately frequently overlooked in practice, and was
designed with busy clinicians in mind. It was used on 40
patients who were representative of the general lung cancer
population who attend the clinic in respect of age, sex,
histology, stage and treatment.6The incidence of
psychological morbidity was similar to that generally
reported in the literature"
The Outlook score calculated by clinicians correlated with
psychological status and quality of life assessed by the
HADS, RSCL and Spitzer QL-Index. The Support score, also
assessed by clinicians, correlated with psychological status
(HADS) but not with quality of life when RSCL and Spitzer
QL-Index were used. However, it did correlate with the
Support question in the Spitzer test carried out by a
psychologist. Overall, the brief scale appears to be effective
as a simple screening device for psychological morbidity_
and quality of life.
Use of this brief scale enables clinicians to include
psychological and social factors in their routine patient
assessments with the aim of making them more
comprehensive and improving patient managementc_
Patients' concerns were uncovered and could be di~ussed,
enabling the clinician to intervene where appropriate or refer
the patients for more specialised attention. Giving qu.ality of
life factors a numerical value by means of a simple sCore
facilitated communication between professional staff, and
also provided a simple means of evaluating the progress of
patients over time.
The brief scale is therefore a cost-effective measure of
quality of life, which is easy to carry out and could be
generally used in oncology. It raises the standard of clinical
care of patients with lung cancer.
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